It has been recently reported that certain cancer cells such as aggressive triple-negative breast cancer cell lines express markers of lipolysis (lipoprotein lipase, LPL) and exogenous fatty acid uptake (CD36), concomitantly with markers of de novo lipogenesis (FASN) [4]. The gene discussed is FASN; the disease is triple-negative breast carcinoma.